Literature DB >> 10562812

Downregulation of p21/WAF1 is related to advanced and dedifferentiated laryngeal squamous cell carcinoma.

P Hirvikoski1, J K Kellokoski, E J Kumpulainen, J A Virtaniemi, R T Johansson, V M Kosma.   

Abstract

AIM: To analyse p21/WAF1 expression and its relation to p53, apoptosis, cell proliferation, clinicopathological characteristics, and patient survival in human laryngeal squamous cell carcinoma.
METHODS: Primary tumours for analyses were obtained from 172 patients with complete follow up data. All patients were treated between 1975 and 1995. Immunohistochemistry was used to evaluate the expression of p21/WAF1, bcl-2, and p53 proteins. The proliferative activity was determined using Ki67 and PCNA antibodies as well as volume corrected mitotic count (M/V index). Volume corrected apoptotic count (A/V index) was determined using an enzymatic in situ cell death detection kit based on the TUNEL method.
RESULTS: High p21 expression was significantly related to high p53 and normal bcl-2 expressions as well as low mitotic count. No association was noticed between p21 expression and apoptotic rate. A significant inverse correlation between p21 expression and advanced stage and poor differentiation was observed, but p21 expression showed no correlation with survival.
CONCLUSIONS: The expression of p21 was associated with tumour stage, histopathological grade, node status, and mitotic count, which may indicate a role for p21 in the progression of laryngeal squamous cell carcinoma.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10562812      PMCID: PMC501431          DOI: 10.1136/jcp.52.6.440

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  37 in total

1.  Physical and functional interaction between wild-type p53 and mdm2 proteins.

Authors:  D S Haines; J E Landers; L J Engle; D L George
Journal:  Mol Cell Biol       Date:  1994-02       Impact factor: 4.272

2.  WAF1, a potential mediator of p53 tumor suppression.

Authors:  W S el-Deiry; T Tokino; V E Velculescu; D B Levy; R Parsons; J M Trent; D Lin; W E Mercer; K W Kinzler; B Vogelstein
Journal:  Cell       Date:  1993-11-19       Impact factor: 41.582

3.  Differentiation-associated overexpression of the cyclin-dependent kinase inhibitor p21waf-1 in human cutaneous squamous cell carcinoma.

Authors:  V A Tron; L Tang; W P Yong; M J Trotter
Journal:  Am J Pathol       Date:  1996-10       Impact factor: 4.307

4.  Expression of cyclin-dependent kinase inhibitor p21WAF1/CIP1 in non-neoplastic mucosa and neoplasia of the stomach: relationship with p53 status and proliferative activity.

Authors:  W Yasui; Y Akama; H Kuniyasu; H Yokozaki; S Semba; F Shimamoto; E Tahara
Journal:  J Pathol       Date:  1996-10       Impact factor: 7.996

5.  p53 and p21(WAF1/CIP1/SDI1) gene products in Barrett esophagus and adenocarcinoma of the esophagus and esophagogastric junction.

Authors:  C A Moskaluk; R Heitmiller; M Zahurak; D Schwab; D Sidransky; S R Hamilton
Journal:  Hum Pathol       Date:  1996-11       Impact factor: 3.466

6.  Abrogation of apoptosis induced by DNA-damaging agents in human bladder-cancer cell lines with p21/WAF1/CIP1 and/or p53 gene alterations.

Authors:  T Kawasaki; Y Tomita; V Bilim; M Takeda; K Takahashi; T Kumanishi
Journal:  Int J Cancer       Date:  1996-11-15       Impact factor: 7.396

7.  Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo.

Authors:  T Miyashita; S Krajewski; M Krajewska; H G Wang; H K Lin; D A Liebermann; B Hoffman; J C Reed
Journal:  Oncogene       Date:  1994-06       Impact factor: 9.867

8.  Reporting results of cancer treatment.

Authors:  A B Miller; B Hoogstraten; M Staquet; A Winkler
Journal:  Cancer       Date:  1981-01-01       Impact factor: 6.860

9.  p53 over-expression is an early event in the development of human squamous-cell carcinoma of the larynx: genetic and prognostic implications.

Authors:  R Dolcetti; C Doglioni; R Maestro; D Gasparotto; L Barzan; A Pastore; M Romanelli; M Boiocchi
Journal:  Int J Cancer       Date:  1992-09-09       Impact factor: 7.396

10.  The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.

Authors:  J W Harper; G R Adami; N Wei; K Keyomarsi; S J Elledge
Journal:  Cell       Date:  1993-11-19       Impact factor: 41.582

View more
  2 in total

1.  Association of TBX2 and P21 expression with clinicopathological features and survival of laryngeal squamous cell carcinoma.

Authors:  Yongjiu Huang; Zufei Li; Qi Zhong; Guojun Li; Yang Zhang; Zhigang Huang
Journal:  Int J Clin Exp Med       Date:  2014-12-15

2.  Analysis of chromosomal aberration (1, 3, and 8) and association of microRNAs in uveal melanoma.

Authors:  Abhirami Radhakrishnan; Nirmala Badhrinarayanan; Jyotirmay Biswas; Subramanian Krishnakumar
Journal:  Mol Vis       Date:  2009-10-22       Impact factor: 2.367

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.